PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease
Clinical trial NCT04052737 · COMPLETED
Trial details
- NCT number
- NCT04052737
- Sponsor
- Pharmazz, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-23
- Primary completion
- 2022-12-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.